...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zhlcf

"These market makers are either nuts or we are."

I'm still trying to understand how the market makers are getting hold of the Zenith CC stock to be able to satisfy unsolicited quotations for the stock. 

Koo

Share
New Message
Please login to post a reply